PapersFlow Research Brief
Mangiferin and Mango Extracts
Research Guide
What is Mangiferin and Mango Extracts?
Mangiferin is a natural xanthone C-glycoside compound found in mango (Mangifera indica) and other plants, while mango extracts are derived from various parts of the mango tree and contain mangiferin along with other bioactive components studied for their therapeutic potential.
Research on mangiferin and mango extracts encompasses 6,438 works focused on health benefits including antioxidant, anti-inflammatory, antidiabetic, anti-obesity, anticancer, neuroprotective, and hepatoprotective effects. "Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats" (2005) demonstrated mangiferin's ability to reduce blood glucose and lipid levels in diabetic models. "Mangifera Indica (Mango)" (2010) reviews the phytochemical profile and pharmacological activities of mango, highlighting mangiferin as a key constituent.
Topic Hierarchy
Research Sub-Topics
Mangiferin Antioxidant Properties
This sub-topic explores mangiferin's free radical scavenging, oxidative stress reduction, and comparative efficacy with other polyphenols. Researchers investigate in vitro assays, cellular mechanisms, and synergistic effects.
Mangiferin Anti-inflammatory Effects
Studies focus on mangiferin's modulation of cytokines, NF-κB pathways, and inflammation markers in various disease models. The sub-topic includes animal and clinical evidence for its role in chronic inflammation.
Mangiferin in Diabetes
Researchers examine mangiferin's effects on glucose metabolism, insulin sensitivity, and β-cell protection in diabetic models. The sub-topic covers pharmacokinetics and combination therapies with antidiabetic agents.
Mangiferin Anticancer Activity
This area investigates mangiferin's apoptosis induction, cell cycle arrest, and anti-proliferative effects across cancer types. Studies emphasize molecular targets like PI3K/Akt and clinical translation potential.
Mangiferin Neuroprotection
Focused on mangiferin's role in mitigating neurodegeneration, ischemia, and neuroinflammation via antioxidant and anti-apoptotic mechanisms. Research includes behavioral models and blood-brain barrier penetration.
Why It Matters
Mangiferin and mango extracts show potential in managing diabetes, as "Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats" (Muruganandan et al., 2005) reported a 28% reduction in blood glucose and lowered atherogenic index in streptozotocin-induced diabetic rats after 28 days of treatment. In obesity and diabetes, "Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids" (Hossain et al., 2016) discusses flavonoids like mangiferin modulating insulin resistance and oxidative stress. "Mango (Mangifera indica L.) by-products and their valuable components: A review" (Jahurul et al., 2015) identifies mango peel and kernel extracts rich in mangiferin for food and pharmaceutical applications, supporting waste valorization in the food industry. "Mangifera Indica (Mango)" (Shah et al., 2010) compiles evidence for mango's use in Ayurvedic medicine against inflammation and metabolic disorders.
Reading Guide
Where to Start
"Mangifera Indica (Mango)" (2010) provides a broad review of mango's phytochemistry and pharmacology, making it ideal for initial understanding of mangiferin and extracts.
Key Papers Explained
"Mangifera Indica (Mango)" (Shah et al., 2010) offers a foundational overview of mangiferin's role in Ayurvedic applications, which "Mango (Mangifera indica L.) by-products and their valuable components: A review" (Jahurul et al., 2015) builds on by focusing on by-product utilization; "Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats" (Muruganandan et al., 2005) then provides targeted evidence of antidiabetic effects, complemented by flavonoid mechanisms in "Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids" (Hossain et al., 2016).
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes pharmacokinetics and targeted applications in diabetes and cancer, as inferred from keyword trends like 'Pharmacokinetics' and abstracts in top papers such as "Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats" (2005).
Papers at a Glance
Latest Developments
Recent research as of February 2026 highlights significant advances in mangiferin and mango extracts, including the development of nanocarriers to improve bioavailability, ongoing market growth projections, and innovative extraction and purification techniques, with studies also exploring their pharmacological properties and potential therapeutic applications (frontiersin.org; pubmed.ncbi.nlm.nih.gov; scientificreports.net).
Sources
Frequently Asked Questions
What is mangiferin?
Mangiferin is a xanthone C-glycoside present in Mangifera indica. "Mangifera Indica (Mango)" (2010) identifies it as a primary bioactive compound with antioxidant and anti-inflammatory properties. It contributes to the pharmacological effects of mango extracts.
How does mangiferin affect diabetes?
Mangiferin reduces hyperglycemia in diabetic rats. "Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats" (2005) showed it lowered blood glucose by 28% and improved lipid profiles. This supports its antidiabetic potential.
What are the components of mango by-products?
Mango by-products like peel and kernel contain mangiferin and other phenolics. "Mango (Mangifera indica L.) by-products and their valuable components: A review" (2015) details their antioxidant-rich composition for health applications. These components offer therapeutic value.
What pharmacological activities does Mangifera indica have?
Mangifera indica exhibits antidiabetic, anti-inflammatory, and antioxidant effects. "Mangifera Indica (Mango)" (2010) reviews studies on its use in Ayurvedic medicine for these properties. Mangiferin drives many of these activities.
How is mangiferin studied in metabolic disorders?
Flavonoids including mangiferin target obesity and diabetes mechanisms. "Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids" (2016) explains their role in reducing insulin resistance and inflammation. This aligns with mangiferin-specific findings.
Open Research Questions
- ? What are the precise molecular pathways by which mangiferin exerts hepatoprotective effects in vivo?
- ? How does mangiferin's bioavailability impact its clinical efficacy for diabetes management?
- ? Which mango extract fractions optimize anticancer activity while minimizing toxicity?
- ? What role does mangiferin play in neuroprotection against specific oxidative stressors?
Recent Trends
The field includes 6,438 works on mangiferin and mango extracts, with keywords highlighting diabetes, obesity, and cancer applications; no growth rate data over 5 years is available, and no recent preprints or news in the last 12 months indicate steady established research rather than rapid expansion.
Research Mangiferin and Mango Extracts with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Mangiferin and Mango Extracts with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers